Addressing patient-reported cognitive impairment in multiple sclerosis clinical practice: A challenging endeavor.
- Published in:
- Multiple Sclerosis Journal, 2025, v. 31, n. 8, p. 896, doi. 10.1177/13524585251334488
- By:
- Publication type:
- Article
Works matching AU Macaron, Gabrielle
Results: 16
1
2
Morvan Syndrome Secondary to Thymic Carcinoma in a Patient with Systemic Lupus Erythematosus.
- Published in:
- Case Reports in Neurological Medicine, 2016, p. 1, doi. 10.1155/2016/9142486
- By:
- Publication type:
- Article
3
Diagnosis and Management of Progressive Multiple Sclerosis.
- Published in:
- Biomedicines, 2019, v. 7, n. 3, p. 56, doi. 10.3390/biomedicines7030056
- By:
- Publication type:
- Article
4
Severe Relapsing Autoimmune Encephalitis with GABA<sub>A</sub> Receptor, Titin, and AchR Antibodies in a Patient with Thymoma: A Case Report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
5
Safety of Newer Disease Modifying Therapies in Multiple Sclerosis.
- Published in:
- Vaccines, 2021, v. 9, n. 1, p. 12, doi. 10.3390/vaccines9010012
- By:
- Publication type:
- Article
6
Association Between Disease-Modifying Therapy and Information Processing Speed in Multiple Sclerosis.
- Published in:
- International Journal of MS Care, 2024, v. 26, n. 3, p. 91, doi. 10.7224/1537-2073.2023-010
- By:
- Publication type:
- Article
7
High fever in myelin oligodendrocyte glycoprotein-associated disorder (MOGAD): A diagnostic challenge.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2023, v. 9, n. 1, p. 1, doi. 10.1177/20552173221148911
- By:
- Publication type:
- Article
8
Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 3, p. 1, doi. 10.1177/2055217319875467
- By:
- Publication type:
- Article
9
Early age of onset predicts severity of visual impairment in patients with neuromyelitis optica spectrum disorder.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 11, p. 1749, doi. 10.1177/1352458520981736
- By:
- Publication type:
- Article
10
Cognitive dysfunction and fatigue during relapses: Taking a better look.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
11
MOG-related disorders: A new cause of imaging-negative myelitis?
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 4, p. 511, doi. 10.1177/1352458519840746
- By:
- Publication type:
- Article
12
Clinical commentary on "Warts and all: Fingolimod and unusual HPV associated lesions".
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 11, p. 1550, doi. 10.1177/1352458518813109
- By:
- Publication type:
- Article
13
Impact of aging on treatment considerations for multiple sclerosis patients.
- Published in:
- Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1197212
- By:
- Publication type:
- Article
14
Schwere rezidivierende Autoimmunenzephalitis mit GABAA-Rezeptor-, Titin- und AChR-Antikörpern bei einem Patienten mit Thymom: ein Fallbericht.
- Published in:
- Kompass Autoimmun, 2024, v. 6, n. 4, p. 189, doi. 10.1159/000541475
- By:
- Publication type:
- Article
15
Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and Adherence.
- Published in:
- Patient Preference & Adherence, 2022, v. 16, p. 1307, doi. 10.2147/PPA.S221882
- By:
- Publication type:
- Article
16
Anxiety, Depression and Suicidal Ideation in Lebanese Patients Undergoing Hemodialysis.
- Published in:
- Community Mental Health Journal, 2014, v. 50, n. 2, p. 235, doi. 10.1007/s10597-013-9669-4
- By:
- Publication type:
- Article